Sionna Therapeutics, Inc. financial data

Symbol
SION on Nasdaq
Location
21 Hickory Drive, Suite 500, Waltham, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.53K %
Debt-to-equity 8.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44.6M shares
Common Stock, Shares, Outstanding 44.5M shares
Common Stock, Value, Issued 44K USD
Weighted Average Number of Shares Outstanding, Basic 44.3M shares +887%
Weighted Average Number of Shares Outstanding, Diluted 44.3M shares +887%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 16M USD -34.7%
General and Administrative Expense 7.76M USD +128%
Operating Income (Loss) -23.8M USD +14.9%
Nonoperating Income (Expense) 3.53M USD +38.7%
Net Income (Loss) Attributable to Parent -20.3M USD +20.3%
Earnings Per Share, Basic -460 USD/shares -8013%
Earnings Per Share, Diluted -460 USD/shares -8013%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 50.8M USD +42.2%
Cash, Cash Equivalents, and Short-term Investments 325M USD
Assets, Current 252M USD
Property, Plant and Equipment, Net 2.14M USD
Operating Lease, Right-of-Use Asset 7.17M USD
Other Assets, Noncurrent 0 USD
Assets 339M USD
Employee-related Liabilities, Current 3.07M USD
Accrued Liabilities, Current 6.93M USD
Liabilities, Current 9.85M USD
Operating Lease, Liability, Noncurrent 7.75M USD
Liabilities 17.6M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 420K USD
Retained Earnings (Accumulated Deficit) -236M USD
Stockholders' Equity Attributable to Parent 322M USD
Liabilities and Equity 339M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.3M USD -23.6%
Net Cash Provided by (Used in) Financing Activities 202M USD +11.6%
Net Cash Provided by (Used in) Investing Activities -141M USD -13.9%
Common Stock, Shares Authorized 500M shares
Common Stock, Shares, Issued 44.5M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 44.9M USD +1.53%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 51.8M USD +41.1%
Depreciation 100K USD -50%
Payments to Acquire Property, Plant, and Equipment 86K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -20M USD +18.2%
Property, Plant and Equipment, Gross 4.11M USD
Operating Lease, Liability, Current 1.22M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 557M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 3.31M USD +222%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares